Harvard Bioscience, Inc. (HBIO)
USD 2.03
(-6.45%)
USD 2.03
(-6.45%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 137.36 Million USD | -5.5% |
| 2022 | 145.36 Million USD | -10.46% |
| 2021 | 162.34 Million USD | 3.9% |
| 2020 | 156.25 Million USD | -5.23% |
| 2019 | 164.87 Million USD | -1.91% |
| 2018 | 168.07 Million USD | 53.7% |
| 2017 | 109.35 Million USD | 1.47% |
| 2016 | 107.76 Million USD | -10.36% |
| 2015 | 120.21 Million USD | -11.55% |
| 2014 | 135.91 Million USD | 0.34% |
| 2013 | 135.46 Million USD | 1.48% |
| 2012 | 133.48 Million USD | 5.41% |
| 2011 | 126.63 Million USD | 1.47% |
| 2010 | 124.79 Million USD | 16.38% |
| 2009 | 107.23 Million USD | 31.94% |
| 2008 | 81.27 Million USD | -17.79% |
| 2007 | 98.85 Million USD | 6.03% |
| 2006 | 93.22 Million USD | 1.3% |
| 2005 | 92.03 Million USD | -34.2% |
| 2004 | 139.88 Million USD | 8.92% |
| 2003 | 128.42 Million USD | 19.38% |
| 2002 | 107.58 Million USD | 30.62% |
| 2001 | 82.36 Million USD | 40.05% |
| 2000 | 58.8 Million USD | 185.34% |
| 1999 | 20.6 Million USD | 185.46% |
| 1998 | 7.22 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 133.16 Million USD | -3.06% |
| 2024 Q2 | 128.91 Million USD | -3.19% |
| 2023 Q2 | 142.89 Million USD | -1.84% |
| 2023 Q3 | 139.73 Million USD | -2.21% |
| 2023 Q4 | 137.36 Million USD | -1.7% |
| 2023 Q1 | 145.57 Million USD | 0.15% |
| 2023 FY | 137.36 Million USD | -5.5% |
| 2022 Q4 | 145.36 Million USD | -1.12% |
| 2022 FY | 145.36 Million USD | -10.46% |
| 2022 Q1 | 158.04 Million USD | -2.65% |
| 2022 Q2 | 155.27 Million USD | -1.75% |
| 2022 Q3 | 147.01 Million USD | -5.32% |
| 2021 Q3 | 153.87 Million USD | -0.06% |
| 2021 FY | 162.34 Million USD | 3.9% |
| 2021 Q1 | 151.24 Million USD | -3.2% |
| 2021 Q2 | 153.97 Million USD | 1.8% |
| 2021 Q4 | 162.34 Million USD | 5.51% |
| 2020 Q1 | 156.26 Million USD | -5.22% |
| 2020 Q2 | 150.68 Million USD | -3.57% |
| 2020 Q3 | 149.61 Million USD | -0.71% |
| 2020 Q4 | 156.25 Million USD | 4.44% |
| 2020 FY | 156.25 Million USD | -5.23% |
| 2019 FY | 164.87 Million USD | -1.91% |
| 2019 Q2 | 166.27 Million USD | -2.96% |
| 2019 Q1 | 171.33 Million USD | 1.94% |
| 2019 Q4 | 164.87 Million USD | 1.29% |
| 2019 Q3 | 162.77 Million USD | -2.1% |
| 2018 Q1 | 170.94 Million USD | 56.32% |
| 2018 FY | 168.07 Million USD | 53.7% |
| 2018 Q4 | 168.07 Million USD | 1.84% |
| 2018 Q3 | 165.04 Million USD | -0.01% |
| 2018 Q2 | 165.05 Million USD | -3.45% |
| 2017 FY | 109.35 Million USD | 1.47% |
| 2017 Q3 | 110.67 Million USD | 1.67% |
| 2017 Q2 | 108.85 Million USD | 1.36% |
| 2017 Q1 | 107.39 Million USD | -0.34% |
| 2017 Q4 | 109.35 Million USD | -1.2% |
| 2016 Q1 | 117.88 Million USD | -1.94% |
| 2016 FY | 107.76 Million USD | -10.36% |
| 2016 Q3 | 112.17 Million USD | -1.67% |
| 2016 Q2 | 114.08 Million USD | -3.22% |
| 2016 Q4 | 107.76 Million USD | -3.93% |
| 2015 Q3 | 133.55 Million USD | -3.62% |
| 2015 Q1 | 134.12 Million USD | -1.32% |
| 2015 FY | 120.21 Million USD | -11.55% |
| 2015 Q2 | 138.57 Million USD | 3.32% |
| 2015 Q4 | 120.21 Million USD | -9.99% |
| 2014 Q3 | 136.12 Million USD | -1.15% |
| 2014 Q2 | 137.7 Million USD | 1.79% |
| 2014 Q4 | 135.91 Million USD | -0.16% |
| 2014 Q1 | 135.29 Million USD | -0.12% |
| 2014 FY | 135.91 Million USD | 0.34% |
| 2013 FY | 135.46 Million USD | 1.48% |
| 2013 Q4 | 135.46 Million USD | -8.68% |
| 2013 Q3 | 148.33 Million USD | 1.57% |
| 2013 Q2 | 146.04 Million USD | 7.83% |
| 2013 Q1 | 135.43 Million USD | 1.46% |
| 2012 Q2 | 129.53 Million USD | -1.5% |
| 2012 Q3 | 130.58 Million USD | 0.81% |
| 2012 Q1 | 131.5 Million USD | 3.85% |
| 2012 Q4 | 133.48 Million USD | 2.22% |
| 2012 FY | 133.48 Million USD | 5.41% |
| 2011 FY | 126.63 Million USD | 1.47% |
| 2011 Q4 | 126.63 Million USD | -0.26% |
| 2011 Q3 | 126.96 Million USD | -1.58% |
| 2011 Q2 | 129.01 Million USD | 1.15% |
| 2011 Q1 | 127.54 Million USD | 2.2% |
| 2010 Q1 | 105.98 Million USD | -1.16% |
| 2010 Q2 | 102.9 Million USD | -2.91% |
| 2010 Q3 | 120.34 Million USD | 16.95% |
| 2010 FY | 124.79 Million USD | 16.38% |
| 2010 Q4 | 124.79 Million USD | 3.7% |
| 2009 Q3 | 106.47 Million USD | 28.94% |
| 2009 Q1 | 79.9 Million USD | -1.68% |
| 2009 FY | 107.23 Million USD | 31.94% |
| 2009 Q4 | 107.23 Million USD | 0.71% |
| 2009 Q2 | 82.57 Million USD | 3.34% |
| 2008 Q3 | 86.66 Million USD | -7.56% |
| 2008 Q1 | 94.56 Million USD | -4.34% |
| 2008 FY | 81.27 Million USD | -17.79% |
| 2008 Q4 | 81.27 Million USD | -6.23% |
| 2008 Q2 | 93.76 Million USD | -0.84% |
| 2007 FY | 98.85 Million USD | 6.03% |
| 2007 Q4 | 98.85 Million USD | 2.47% |
| 2007 Q3 | 96.47 Million USD | 6.81% |
| 2007 Q2 | 90.31 Million USD | -1.3% |
| 2007 Q1 | 91.5 Million USD | -1.85% |
| 2006 Q4 | 93.22 Million USD | 2.85% |
| 2006 FY | 93.22 Million USD | 1.3% |
| 2006 Q3 | 90.64 Million USD | -1.97% |
| 2006 Q2 | 92.46 Million USD | 0.67% |
| 2006 Q1 | 91.85 Million USD | -0.2% |
| 2005 Q4 | 92.03 Million USD | -13.84% |
| 2005 Q2 | 107.47 Million USD | -20.87% |
| 2005 Q3 | 106.81 Million USD | -0.62% |
| 2005 FY | 92.03 Million USD | -34.2% |
| 2005 Q1 | 135.82 Million USD | -2.9% |
| 2004 FY | 139.88 Million USD | 8.92% |
| 2004 Q4 | 139.88 Million USD | 3.99% |
| 2004 Q3 | 134.5 Million USD | 0.51% |
| 2004 Q1 | 136.42 Million USD | 6.23% |
| 2004 Q2 | 133.83 Million USD | -1.9% |
| 2003 Q3 | 119.33 Million USD | 2.46% |
| 2003 FY | 128.42 Million USD | 19.38% |
| 2003 Q1 | 115.65 Million USD | 7.5% |
| 2003 Q2 | 116.47 Million USD | 0.7% |
| 2003 Q4 | 128.42 Million USD | 7.62% |
| 2002 Q1 | 83.57 Million USD | 1.47% |
| 2002 FY | 107.58 Million USD | 30.62% |
| 2002 Q2 | 83.53 Million USD | -0.04% |
| 2002 Q4 | 107.58 Million USD | 26.73% |
| 2002 Q3 | 84.89 Million USD | 1.62% |
| 2001 FY | 82.36 Million USD | 40.05% |
| 2001 Q2 | 73.53 Million USD | 13.8% |
| 2001 Q3 | 74.49 Million USD | 1.31% |
| 2001 Q1 | 64.61 Million USD | 9.88% |
| 2001 Q4 | 82.36 Million USD | 10.56% |
| 2000 FY | 58.8 Million USD | 185.34% |
| 2000 Q4 | 58.8 Million USD | 0.0% |
| 1999 FY | 20.6 Million USD | 185.46% |
| 1998 FY | 7.22 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 180.36 Million USD | 23.842% |
| AngioDynamics, Inc. | 317.67 Million USD | 56.758% |
| AtriCure, Inc. | 613.93 Million USD | 77.625% |
| Avinger, Inc. | 13.77 Million USD | -897.574% |
| Azenta, Inc. | 2.88 Billion USD | 95.24% |
| BioLife Solutions, Inc. | 412.71 Million USD | 66.716% |
| The Cooper Companies, Inc. | 11.65 Billion USD | 98.822% |
| Daxor Corporation | 34.86 Million USD | -293.947% |
| Ekso Bionics Holdings, Inc. | 28.91 Million USD | -375.019% |
| Femasys Inc. | 27.75 Million USD | -394.909% |
| GlucoTrack, Inc. | 4.9 Million USD | -2700.53% |
| Hologic, Inc. | 9.15 Billion USD | 98.5% |
| ICU Medical, Inc. | 4.37 Billion USD | 96.863% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | 99.11% |
| KORU Medical Systems, Inc. | 28.46 Million USD | -382.647% |
| LeMaitre Vascular, Inc. | 346.77 Million USD | 60.388% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -2108.896% |
| Innovative Eyewear, Inc. | 6.21 Million USD | -2108.896% |
| Masimo Corporation | 3.04 Billion USD | 95.484% |
| Microbot Medical Inc. | 8.32 Million USD | -1549.646% |
| Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | 20.097% |
| Merit Medical Systems, Inc. | 2.32 Billion USD | 94.092% |
| Nephros, Inc. | 11.86 Million USD | -1058.132% |
| NovoCure Limited | 1.14 Billion USD | 88.015% |
| NEXGEL, Inc. | 9.95 Million USD | -1279.869% |
| NEXGEL, Inc. | 9.95 Million USD | -1279.869% |
| Singular Genomics Systems, Inc. | 265.46 Million USD | 48.255% |
| OraSure Technologies, Inc. | 482.84 Million USD | 71.551% |
| Pro-Dex, Inc. | 54.21 Million USD | -153.396% |
| Pulse Biosciences, Inc. | 60.8 Million USD | -125.916% |
| Predictive Oncology Inc. | 14.41 Million USD | -852.789% |
| Precision Optics Corporation, Inc. | 16.91 Million USD | -712.212% |
| QuidelOrtho Corporation | 8.56 Billion USD | 98.396% |
| Repligen Corporation | 2.82 Billion USD | 95.136% |
| Sanara MedTech Inc. | 73.87 Million USD | -85.954% |
| STAAR Surgical Company | 488.69 Million USD | 71.891% |
| Sharps Technology, Inc. | 11.78 Million USD | -1065.178% |
| Utah Medical Products, Inc. | 135.45 Million USD | -1.409% |
| DENTSPLY SIRONA Inc. | 7.37 Billion USD | 98.136% |
| Jin Medical International Ltd. | 32.9 Million USD | -317.482% |